This shows we have much to learn about the role of
Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2022 – Apr 2023Where it's discussed
-
X / Twitter15 posts
-
News5 articles
-
Blogs4 articles
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
Overall, the collective social discussions demonstrate strong support for dietary management of IBS, citing specific data like symptom improvement (e.g., higher responder rates with diet) and expressing curiosity about practical tools like diet apps. The tone combines optimistic evaluation with questions about accessibility, contributing to a balanced view of the study's implications and potential impact in primary care settings.
Most discussions support the findings favoring diet over medication for IBS, indicating positive consensus about the study's conclusions.
There is high interest, as many discussions highlight benefits of dietary approaches like the FODMAP diet and question the availability of related apps.
Posts show some in-depth engagement by referencing specific aspects of the study, such as statistical improvements and implications for primary care, though few offer detailed critique.
The discussions acknowledge the potential influence of the study on IBS management practices and raise questions about practical tools, hinting at moderate impact on future clinical approaches.
Abstract in brief
- The study compares the effectiveness of a FODMAP-lowering diet app versus the muscle relaxant medication otilonium bromide (OB) in treating IBS symptoms in primary care patients, finding that the diet was more effective after 8 weeks and had higher adherence rates.
- Patients following the diet showed a higher responder rate and sustained symptom improvement during a 24-week follow-up, with women and those with lower depression scores more likely to respond.
- The findings suggest that implementing a smartphone-based FODMAP diet could be a better initial treatment approach for IBS patients in primary care settings than traditional medication.
Top posts
Most liked on X and BlueskyIBS患者に対するスマホアプリを用いた食事療法 ・IBS患者における低FODMAP食治療スマホアプリ vs 内服治療(鎮痙剤) ・アプリの使用により、症状改善率(71% vs 61%)、アドヒアランス率(94 vs 73%)共に有意に高かった スマホアプリによる治療介入はIBSとの相性もいいですね https://t.co/3m1QF4bV0d
Diet continues to show benefit in Irritable Bowel Syndrome (IBS) - using a FODMAP diet. This study done in UK Primary Care. #FODMAP #IBS #diet https://t.co/XuZxkNBhd2
a #FODMAP-lowering diet application was superior to a spasmolytic agent in improving #IBS symptoms https://t.co/KJcCH909Mp via @GUTJournal_BMJ But who can remember what #foods contain FODMAPS? #nutrition
▼IBS患者において低FODMAP食は、鎮痙剤よりも大きな改善を期待できる可能性 https://t.co/sICxOMeiNI 有意に高い反応率は4週間後に既に確認され(62% vs 51%)、Rome+でより顕著な効果が確認されたとのこと。アドヒアランスも高く(94% vs 73%)、選択肢としての優先順位は高め?
昨日の抄読会ではIBSに対するアプリを使用した食事療法の有効性について勉強しました。 Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian ... https://t.co/7jJ3u55rHA
All mentions
Natural Interventions Outperform Pharmaceuticals for IBS Treatment
Natural interventions like fasting, cold therapy, nutrition, and sleep hygiene are often more effective than pharmacological treatments for irritable bowel syndrome, as supported by numerous studies and recent research…
FODMAP Diet Outperforms Medication for IBS Treatment
The study compares a FODMAP-lowering diet app versus medication in primary care IBS patients, finding the diet more effective after 8 weeks with higher adherence and sustained symptom improvement over 24 weeks.
Another study - Diet > meds. this one in IBS using a FODMAP diet. #nutrition #FODMAP #diet https://t.co/XuZxkNTqra
昨日の抄読会ではIBSに対するアプリを使用した食事療法の有効性について勉強しました。 Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian ... https://t.co/7jJ3u55rHA
IBS患者に対するスマホアプリを用いた食事療法 ・IBS患者における低FODMAP食治療スマホアプリ vs 内服治療(鎮痙剤) ・アプリの使用により、症状改善率(71% vs 61%)、アドヒアランス率(94 vs 73%)共に有意に高かった スマホアプリによる治療介入はIBSとの相性もいいですね https://t.co/3m1QF4bV0d
@thecurbsiders This is the study on IBS from the digest. Do you know if the app they used is publicly available? I didn’t find a name for it in the abstract. There are number of apps out there for this but not sure I can recommend any particular ones. https://t.co/sH9FnSf2DV
Diet continues to show benefit in Irritable Bowel Syndrome (IBS) - using a FODMAP diet. This study done in UK Primary Care. #FODMAP #IBS #diet https://t.co/XuZxkNBhd2
a #FODMAP-lowering diet application was superior to a spasmolytic agent in improving #IBS symptoms https://t.co/KJcCH909Mp via @GUTJournal_BMJ But who can remember what #foods contain FODMAPS? #nutrition
これ知っておくといいかも EvidenceAlerts | Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute. https://t.co/ZrtT6lQfhi
PCPs- in suspected IBS cases,
▼IBS患者において低FODMAP食は、鎮痙剤よりも大きな改善を期待できる可能性 https://t.co/sICxOMeiNI 有意に高い反応率は4週間後に既に確認され(62% vs 51%)、Rome+でより顕著な効果が確認されたとのこと。アドヒアランスも高く(94% vs 73%)、選択肢としての優先順位は高め?
RT @KewinSiah: This shows we have much to learn about the role of
RT @KewinSiah: This shows we have much to learn about the role of
RT @KewinSiah: This shows we have much to learn about the role of
RT @KewinSiah: This shows we have much to learn about the role of
RT @KewinSiah: This shows we have much to learn about the role of
This shows we have much to learn about the role of